ARS Pharmaceuticals Inc’s recently made public that its Chief Commercial Officer Karas Eric unloaded Company’s shares for reported $0.14 million on Mar 20 ’25. In the deal valued at $14.00 per share,10,000 shares were sold. As a result of this transaction, Karas Eric now holds 7,696 shares worth roughly $96815.68000000001.
Then, ERIC KARAS bought 10,000 shares, generating $140,000 in total proceeds.
Before that, Shawver Laura sold 49,600 shares. ARS Pharmaceuticals Inc shares valued at $556,046 were divested by the Director at a price of $11.21 per share. As a result of the transaction, Shawver Laura now holds 210,346 shares, worth roughly $2.65 million.
Scotiabank initiated its ARS Pharmaceuticals Inc [SPRY] rating to a Sector outperform in a research note published on March 07, 2025; the price target was $30. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in early February with a ‘”an Outperform”‘ rating. Cantor Fitzgerald began covering SPRY with “an Overweight” recommendation on August 20, 2024. Raymond James revised its rating on August 13, 2024. It rated SPRY as “a Strong buy” which previously was an “an Outperform”.
Price Performance Review of SPRY
On Monday, ARS Pharmaceuticals Inc [NASDAQ:SPRY] saw its stock jump 0.72% to $12.58. Over the last five days, the stock has lost -2.40%. ARS Pharmaceuticals Inc shares have risen nearly 19.24% since the year began. Nevertheless, the stocks have risen 26.31% over the past one year. While a 52-week high of $18.51 was reached on 01/27/25, a 52-week low of $7.55 was recorded on 03/04/25. SMA at 50 days reached $12.16, while 200 days put it at $12.40.
Levels Of Support And Resistance For SPRY Stock
The 24-hour chart illustrates a support level at 12.03, which if violated will result in even more drops to 11.48. On the upside, there is a resistance level at 12.95. A further resistance level may holdings at 13.32. The Relative Strength Index (RSI) on the 14-day chart is 54.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.41%. Stochastics %K at 41.85% indicates the stock is a holding.
How much short interest is there in ARS Pharmaceuticals Inc?
A steep rise in short interest was recorded in ARS Pharmaceuticals Inc stocks on 2025-03-14, growing by 2.95 million shares to a total of 19.43 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 16.48 million shares. There was a rise of 15.16%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 12, 2024 when Leerink Partners resumed its ‘”an Outperform”‘ rating for the stock and retained the price target to $20.
